Runta Medical had one block trade on March 25, with a total transaction amount of 4.45M yuan and a premium rate of -9.93%.

robot
Abstract generation in progress

For stock trading, just rely on the Golden Qilin analyst research reports—authoritative, professional, timely, and comprehensive. Help you uncover potential themes and investment opportunities!

On March 25, RunDa Medical rose 0.08%, closing at 12.99 yuan. There was 1 block trade, with a total traded volume of 380k shares and a transaction value of 380k yuan.

The first trade’s execution price was 11.70 yuan, with 380.00 thousand shares traded and a transaction value of 4.4460 million yuan. The premium rate was -9.93%. The buying party’s business department was Guotai Huarong Securities Co., Ltd.’s Shanghai Changning District Tianshan West Road Securities business department, and the selling party’s business department was CITIC Jianxin Securities Co., Ltd.’s Hangzhou Qingchun Road Securities business department.

Further statistics show that within the past three months, this stock has had 2 block trades in total, with an aggregate transaction value of 4.45M yuan. Over the past five trading days, the stock has cumulatively fallen by 11.03%, and main force funds have totaled a net outflow of 134 million yuan.

Statement: The market involves risk, and investors should be cautious. This article is automatically published based on a third-party database and does not represent Sina Finance’s views. Any information appearing in this article is for reference only and does not constitute personal investment advice. If there are discrepancies, please refer to the actual announcements. If you have any questions, please contact biz@staff.sina.com.cn.

A massive amount of information and precise analysis—right here in the Sina Finance app

责任编辑:小浪快报

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments